Role of Homoeopathic Medicine In The Treatment of Benign Prostatic Hyperplasia
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2024/05/067640
- Lead Sponsor
- ational Institute of Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
A) Patients of age group of 40-80 years
B) Patients presenting symptoms of Benign prostatic hyperplasia with or without evidence of
bladder outflow obstruction with AUASS more than 7
C) Patient suffering from cases of Benign Prostatic Hyperplasia diagnosed radiologically (USG Pelvis) and Ultrasonographic examination of prostate weight more than 20 g or 20 cc and RUV of more than 30ml
D) Male patients of all religions and of different socioeconomic status
E) Patients with known but controlled systemic diseases
F) Patients who are willing to give consent to participate in the study
G) Patient who can read and/or understand Hindi or Bengali or English
A) Patients with Serum Prostate specific antigen (PSA) more than 4 nmol per mL to rule out suspected prostatic malignancy
B) Cases suffering from uncontrolled systemic illness or life-threatening conditions
C) Patient suffering from complete retention of urine for more than 24hrs
D) Patient having any psychiatric illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AMERICAN UROLOGICAL ASSOCIATION Symptom Score (AUASS)Timepoint: Baseline, 3rd month and 6th month
- Secondary Outcome Measures
Name Time Method SG for prostate size and residual urine volumeTimepoint: Baseline and 6th month